NewEdge Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $19.4K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $18 | Hold |
|
|||||
|
2022
Q4 | $0 | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $8K | Hold |
|
|||||
|
2019
Q3 | $10K | Sell |
|
|||||
|
2019
Q2 | $11K | Buy |
|
|||||
|
2019
Q1 | $13K | Hold |
|
|||||
|
2018
Q4 | $9 | Sell |
|
|||||
|
2018
Q3 | $71K | Buy |
|
|||||
|
2018
Q2 | $41 | Sell |
|
|||||
|
2018
Q1 | $64K | Buy |
|
|||||
|
2017
Q4 | $42K | Buy |
|